The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BC
BCG immunotherapy is safe in immunocompromised patients. Nevertheless, the efficacy of intravesical BCG in these patients might be suboptimal thus advocating the need for appropriate counselling and a possible lower threshold to consider radical treatment.
Authors
- Ben J Challacombe (ORCID: https://orcid.org/0000-0001-8631-0314)
- Roberto Contieri (ORCID: https://orcid.org/0000-0001-7011-0537)
- Francesco Soria (ORCID: https://orcid.org/0000-0001-8443-8453)
- Wojciech Krajewski (ORCID: https://orcid.org/0000-0003-1727-2283)
- Muhammad Shamim Khan (ORCID: https://orcid.org/0000-0002-1861-0830)
- Carlo Buonerba (ORCID: https://orcid.org/0000-0002-1806-442X)
- Yasmin Abu‐Ghanem (ORCID: https://orcid.org/0000-0003-3682-5963)
- Tomasz Szydełko (ORCID: https://orcid.org/0000-0002-1360-0422)
- Bernardo Rocco (ORCID: https://orcid.org/0000-0002-9135-0035)
- Keiichiro Mori (ORCID: https://orcid.org/0000-0002-6147-6569)
- Mohamed Gad (ORCID: https://orcid.org/0000-0002-5603-597X)
- Felice Crocetto (ORCID: https://orcid.org/0000-0002-4315-7660)
- Roman Mayr (ORCID: https://orcid.org/0000-0003-1796-3260)
- Jung Ki Jo (ORCID: https://orcid.org/0000-0002-6080-7493)
- Valerio Santarelli (ORCID: https://orcid.org/0009-0009-9689-438X)
- Rajesh Nair (ORCID: https://orcid.org/0000-0001-7911-4972)
- José Daniel Subiela (ORCID: https://orcid.org/0000-0003-4176-8174)
- Łukasz Nowak (ORCID: https://orcid.org/0000-0003-4273-8196)
- Renate Pichler (ORCID: https://orcid.org/0000-0001-5286-9048)
- Benjamin Inbeh Chung (ORCID: https://orcid.org/0000-0001-9660-2732)
- Marco Moschini (ORCID: https://orcid.org/0000-0002-3084-2458)
- Benjamin Pradere
- Biagio Barone (ORCID: https://orcid.org/0000-0003-4884-132X)
- Shufeng Li (ORCID: https://orcid.org/0000-0003-0584-3325)
- Andrea Mari (ORCID: https://orcid.org/0000-0001-9070-5706)
- Elsie Mensah (ORCID: https://orcid.org/0000-0003-1688-9767)
- Francesco Del Giudice (ORCID: https://orcid.org/0000-0003-3865-5988)
- Jan Łaszkiewicz (ORCID: https://orcid.org/0009-0008-2306-0854)
- Ramesh Thurairaja
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Jikei University School of Medicine (JP)
- AOL (United States) (US)
- St Thomas' Hospital (GB)
- Humanitas University (IT)
- Innsbruck Medical University (AT)
- Universidad de Alcalá (ES)
- Universität Innsbruck (AT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Policlinico Umberto I (IT)
- Wroclaw Medical University (PL)
- Ospedale San Paolo (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- CTO Andrea Alesini (IT)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Lyon Genou Centre Albert Trillat (FR)
- IRCCS Ospedale San Raffaele (IT)
- Stanford Medicine (US)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Hospital Universitario Ramón y Cajal (ES)
- University of Florence (IT)
- Hanyang University (KR)
- University of Regensburg (DE)
- University of Naples Federico II (IT)
- Sapienza University of Rome (IT)
- Stanford University (US)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.urolonc.2025.07.005
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00